Orange Book product · Generic (ANDA)
RESERPINE AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; RESERPINE
At a glance
Jan 31, 1984
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 31, 1984
43 yr ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; RESERPINE
Strength
50MG;0.125MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 088200
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; RESERPINE
- —HYDROPRES 25Brand (NDA)
NDA 011958 · MERCK
- —SERPASIL-ESIDRIX #1Brand (NDA)
NDA 011878 · NOVARTIS
- 1984RESERPINE AND HYDROCHLOROTHIAZIDE-50Generic (ANDA)
ANDA 088189 · WEST WARD
- 1982HYDRO-RESERPGeneric (ANDA)
ANDA 084714 · ABC HOLDING
- —H.R.-50Generic (ANDA)
ANDA 085338 · WHITEWORTH TOWN PLSN
- —"HYDRO-SERP ""25"""Generic (ANDA)
ANDA 084827 · SANDOZ
- —"HYDRO-SERP ""50"""Generic (ANDA)
ANDA 085213 · SANDOZ
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083572 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083571 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083568 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 083573 · IVAX SUB TEVA PHARMS
- —HYDROCHLOROTHIAZIDE W/ RESERPINEGeneric (ANDA)
ANDA 085421 · PHARMERAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
